Company profile: Syndesi Therapeutics
1.1 - Company Overview
Company description
- Provider of drug candidates and molecules that uniquely modulate the synaptic vesicle protein SV2A to regulate synaptic transmission, representing a promising approach to treating Alzheimer’s disease and other neurological disorders with cognitive impairment.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Syndesi Therapeutics
Microbia
HQ: United States
Website
- Description: Provider of industrial biotechnology, developing, producing, and commercializing fermentation-based specialty ingredients and biomaterials, including carotenoids, biopolymers, and other biomaterials; maintains a strategic alliance with Tate & Lyle Investments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microbia company profile →
Scireq
HQ: Canada
Website
- Description: Provider of laboratory equipment for preclinical respiratory research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scireq company profile →
Arzeda
HQ: United States
Website
- Description: Provider of AI-driven protein and enzyme design and manufacturing for pharmaceuticals, industrial chemicals, and food applications. Offers Intelligent Protein Design Technology to create novel proteins; ProSweet enzymes for efficient production of Reb D and Reb M from stevia; and collaborates with Unilever (cleaning), W. L. Gore (materials), Takeda (therapeutic biologics), and AAK (plant-based oils).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arzeda company profile →
bit.bio
HQ: United Kingdom
Website
- Description: Provider of proprietary cell programming technology and human iPSC-derived cell products for research and drug discovery. Bit.bio develops opti-ox to convert iPSCs into mature, functional human cells and offers ioCells for consistent, scalable supply. The company applies computational principles to biology to code cells for health, including collaboration with The Michael J. Fox Foundation on Parkinson’s research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full bit.bio company profile →
Akadeum Life Sciences
HQ: United States
Website
- Description: Provider of bioseparation products that facilitate the removal of target cells from biological samples.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akadeum Life Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Syndesi Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Syndesi Therapeutics
2.2 - Growth funds investing in similar companies to Syndesi Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Syndesi Therapeutics
4.2 - Public trading comparable groups for Syndesi Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →